Vertex, Incyte Fall; Precigen, Magnachip Rise
Vertex, Incyte Fall; Precigen, Magnachip Rise
Stocks that traded heavily or had substantial price changes Friday:

NEW YORK: Stocks that traded heavily or had substantial price changes Friday:

Vertex Pharmaceuticals Inc., down $23.75 to $193.02.

The biotechnology company ended development of a potential treatment for a genetic condition that targets the liver.

Dave & Buster’s Entertainment Inc., down $1.21 to $42.87.

Investors remained cautious about the beaten down restaurant and arcade owner, despite reporting surprisingly good first-quarter earnings.

Incyte Corp., down $4.95 to $82.58.

The biotechnology company’s potential eczema cream ruxolitinib faces a delayed regulatory review.

Precigen Inc., up 34 cents to $7.33.

The biotechnology company gave investors an encouraging development update for a potential diabetes treatment.

Magnachip Semiconductor Corp., up $2.86 to $25.91.

The chipmaker, which agreed to a buyout from South Dearborn, received a bigger offer from Cornucopia Investment Partners.

Royal Caribbean Group, down 54 cents to $90.09.

The cruise line operator said two guests sharing a stateroom onboard its Celebrity Millennium tested positive for COVID-19.

MKS Instruments Inc., down $3.78 to $177.56.

The maker of analysis and processing equipment for semiconductor companies is reportedly seeking to buy Atotech.

Western Digital Corp., up $1.22 to $74.78.

The maker of hard drives for businesses and personal computers gave investors an encouraging update during a business conference.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Read all the Latest News, Breaking News and Coronavirus News here.

What's your reaction?

Comments

https://umatno.info/assets/images/user-avatar-s.jpg

0 comment

Write the first comment for this!